Telix Pharmaceuticals (ASX:TLX) Acquires TheraPharm - Sequoia Direct Pty Ltd

30NovNovember 30, 2020

Telix Pharmaceuticals (ASX:TLX) Acquires TheraPharm

Telix Pharmaceuticals (ASX:TLX) has entered into an agreement with Scintec Diagnostics GmbH to acquire TheraPharm GmbH.

TheraPharm is a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in the field of haematology.

The acquisition of TheraPharm provides Telix with access to a portfolio of patents, technologies, production systems, clinical data and know-how in relation to the use of Molecularly Targeted Radiation (MTR) in haematology and immunology.

TheraPharm is developing antibody MTR technology against CD66, a cell surface target highly expressed by neutrophils (a type of granulocyte, a category of white blood cell) and tumour-infiltrating lymphocytes.

As such, the technology has potentially very broad applications in the diagnosis and treatment of hematologic diseases (e.g. blood cancers), infection management and a variety of lymphoproliferative diseases.

Telix Pharmaceuticals (ASX:TLX) are trading 7.4 per cent higher at $3.49.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

29SepSeptember 29, 2020

Atomo Diagnostics (ASX:AT1) expand partnership for Covid-19 test

29 Sep 2020 - Atomo Diagnostics (ASX:AT1) is pleased to announce it has expanded its existing Covid-19 rapid test partnership with Access Bio LLC.

09AugAugust 9, 2024

Stocks of the Hour: Pointerra, EVZ, Sarytogan Graphite

09 Aug 2024 - A snapshot of the stocks on the move, featuring Pointerra (ASX:3DP), EVZ (ASX:EVZ) and Sarytogan Graphite (ASX:SGA).

19NovNovember 19, 2020

Shopping Centres Australasia Property Group (ASX:SCP) buy a NSW shopping centre

19 Nov 2020 - Shopping Centres Australasia Property Group (ASX:SCP) has agreed to buy Auburn Central Shopping Centre in New South Wales for $129.5 million.

19DecDecember 19, 2019

Service Stream (ASX:SSM) wins Sydney Water Contract

19 Dec 2019 - Service Stream (ASX:SSM) subsidiary Comdain, has been awarded a ten-year agreement by Sydney Water.

24FebFebruary 24, 2020

Jumbo Interactive (ASX:JIN) increase dividend to 18.5 cents

24 Feb 2020 - Lottery provider Jumbo Interactive (ASX:JIN) report net profit after tax rose 14 per cent to $14.4 million and EBITDA rose 17 per cent to $22.9 million on the same corresponding period.

11FebFebruary 11, 2021

Telstra (ASX:TLS) reports a 2.2% drop in profit to $1.12 billion

11 Feb 2021 - Telstra (ASX:TLS) reports a 2.2 per cent drop in profit to $1.12 billion.

05SepSeptember 5, 2019

TPG Telecom FY profit falls 56%

05 Sep 2019 - TPG Telecom (ASX:TPM) has today announced its results for its financial year ended 31 July 2019 showing net profit down 56.1 per cent to $173.8 million.

22AprApril 22, 2024

Stocks of the Hour: Base Resources, Lanthanein Resources, Orion Minerals, Novonix

22 Apr 2024 - A snapshot of the stocks on the move, featuring Base Resources, Lanthanein Resources, Orion Minerals and Novonix.

23JunJune 23, 2023

Stocks of the Hour: Tamboran Resources, Solis Minerals, North Stawell Minerals

23 Jun 2023 - A snapshot of the stocks on the move, featuring Tamboran Resources, Solis Minerals, North Stawell Minerals.

15AprApril 15, 2021

Recce Pharmaceticals (ASX:RCE) lead compound ready to start clinical trials for topical wound application

15 Apr 2021 - Recce Pharmaceticals’ (ASX:RCE) lead compound RECCE® 327 has been registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) for its Phase I/II Topical Burns Study in humans.